Coventry Releases Part Three of its Annual Drug Trends Series to Address Opioids
Thursday, August 22, 2019 | 560 | 0
Downers Grove, IL. (August 21, 2019) - Coventry, a leading provider of care and cost management solutions for workers' compensation, has releases part three of its Annual Drug Trends Series. In part three of our series we look at opioids, which continue to decrease in proportion to overall scripts and costs, with favorable trends in Morphine Equivalent Dose (MED), duration of use, and access to guideline-supported measures including Medication-Assisted Treatment (MAT) and overdose rescue medications. Some highlights from the series include:
- Opioid script cost fell by nearly 2%
- The number of injured workers using opioids has declined for 5 consecutive years
- High MED prescriptions had their most significant decrease in 4 years
Each part in the series is accompanied by a deeper dive into various related topics to address specific trends highlighted in the drug trend series. To find out more, visit the Coventry Blog Page.
All the editions of the series can be found on our Drug Trends Page.
About Coventry
Coventry is the leading provider of care and cost management solutions for workers' comp, disability and auto insurance carriers, third-party administrators, and self-insured employers. We design best-in-class products and services to help our partners return injured workers to work, to play, and to life as quickly and as cost effectively as possible. We accomplish this by developing and maintaining consultative partnerships with our clients and stakeholders, built on a foundation of trust that supports the claims management process.
CONTACT:
Coventry
info@cvty.com
800.790.8662